Morgans Under the Microscope
Morgans Financial Limited
Add to My Podcasts
Episodes
About
Reviews
Promote
Under the microscope: Resmed (ASX:RMD) - Derek Jellinek, Senior Analyst
5 minutes
Posted May 4, 2020 at 2:19 am.
0:00
5:30
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Morgans Senior Analyst Derek Jellinek discusses RMD 3Q results and strong resilience shown across the core business and incremental gains from COVID-19 induced demand for ventilators.
Previous
Under the microscope: Weekly Wrap - Week Ending 24 April
Next
Under the microscope: Volpara Health Technologies (ASX:VHT) - Scott Power, Senior Analyst
← See all 96 episodes of Morgans Under the Microscope